Status:
COMPLETED
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsors:
Institut des Maladies Rares
National Research Agency, France
Conditions:
Cerebellar Ataxias
Spastic Paraplegias
Eligibility:
All Genders
2-70 years
Brief Summary
Cerebellar ataxias (CA) and spastic paraplegias (SP) are genetically and clinically very heterogeneous. More than 40 loci are already known but the number of phenotypes is even greater suggesting furt...
Eligibility Criteria
Inclusion
- Progressive ataxia or paraplegia
Exclusion
- Lack of signed informed consent
Key Trial Info
Start Date :
February 10 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT00140829
Start Date
February 10 2004
End Date
December 30 2020
Last Update
February 4 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Mustapha
Algiers, Algeria, 16000
2
Université Libre de Bruxelles - Hôpital Erasme
Brussels, Belgium, 1070
3
The Panum Institute
Copenhagen, Denmark, 2200
4
CHU d'Angers
Angers, France, 49000